Back

CME Outfitters, LLC

  • Metrorrhagia
  • Non-alcoholic Fatty Liver Disease
  • Obesity

Spotting the Red Flags: Screening and Risk Strat Like a Pro

Metabolic dysfunction-associated steatohepatitis (MASH) is a growing clinical challenge due to its increasing prevalence, complex pathophysiology, and strong association with comorbid conditions such as cardiovascular disease and obesity. Evolving diagnostic criteria, risk stratification tools, and new therapeutic options require health care professionals (HCPs) to remain continuously informed and adaptable. A critical first step in management is initial screening something both primary care practitioners and specialists can address using routine blood work and the Ffibrosis-4 (FIB-4) calculation. Subsequent non-invasive liver disease assessment (NILDA) should follow, as appropriate. In this first of four CME Outfitters Snacks, expert faculty will share guideline recommendations and best practices for optimizing initial screening and risk stratification of patients at risk for MASH.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 0.5 creditsAMA PRA Category 1 Credit™Up to 0.5 creditsNursingUp to 0.5 creditsPharmacyUp to 0.5 credits

MOC types

ABIM — Medical KnowledgeUp to 0.5 points

FDA REMS

No

Qualifies for MIPS

Yes

Faculty 2

All faculty
  • Conan Tu, MD

    Regional Chief of Adult Primary Care, Eastern Long Island, Optum Medical Care of New York & New Jersey

    General Internal Medicine

  • Arun Jesudian, MD

    Associate Professor of Clinical Medicine, Weill Cornell Medicine

Pricing

Free

Reported to ACCME by the provider

  • On-demand / recorded video
  • Credit · Up to 0.5 credits
  • MOC · Up to 0.5 points
  • Commercial Support
  • Released
    Oct 13, 2025
  • Last day to claim credit
    Jan 1, 2027 3 months left